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Finding disease markers (classiﬁers) from gene expression data by machine learning algorithms is characterized by a high risk of
overﬁtting the data due the abundance of attributes (simultaneously measured gene expression values) and shortage of available
examples (observations). To avoid this pitfall and achieve predictor robustness, state-of-the-art approaches construct complex clas-
siﬁers that combine relatively weak contributions of up to thousands of genes (attributes) to classify a disease. The complexity of
such classiﬁers limits their transparency and consequently the biological insights they can provide. The goal of this study is to apply
to this domain the methodology of constructing simple yet robust logic-based classiﬁers amenable to direct expert interpretation. On
two well-known, publicly available gene expression classiﬁcation problems, the paper shows the feasibility of this approach, employ-
ing a recently developed subgroup discovery methodology. Some of the discovered classiﬁers allow for novel biological
interpretations.
 2004 Elsevier Inc. All rights reserved.
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Gene expression monitoring by DNA microarrays
(gene chips) provides an important source of informa-
tion that can help in understanding many biological pro-
cesses. This technology allows for novel applications,
resulting in increased understanding of disease pro-
cesses, and improved diagnosis and prediction in
medicine.1532-0464/$ - see front matter  2004 Elsevier Inc. All rights reserved.
doi:10.1016/j.jbi.2004.07.007
* Corresponding author. Fax: +385 1 4680 114.
E-mail addresses: dragan.gamberger@irb.hr (D. Gamberger),
nada.lavrac@ijs.si (N. Lavracˇ), zelezny@fel.cvut.cz, zelezny@biostat.
wisc.edu (F. Zˇelezny´), tolar003@umn.edu (J. Tolar).Data collected in these applications are not suitable
for direct human explanatory analysis because a single
DNA microarray experiment results in thousands of
measured expression values and also because of the lack
of existing expert knowledge available for the analysis.
The application of various data mining and knowledge
discovery methods using machine learning algorithms
[39] seems an evident approach to take in such a prob-
lem domain. Numerous approaches have been suggested
towards exploiting state-of-the-art machine learning or
microarray data mining, including both supervised
learning (learning from data with class labels) and unsu-
pervised learning (such as conceptual clustering). A
state-of-the-art review of these various approaches can
be found in [15,40].
270 D. Gamberger et al. / Journal of Biomedical Informatics 37 (2004) 269–284In this study, we follow the supervised learning para-
digm. The database we analyze consists of a set of gene
expression measurements (examples), each correspond-
ing to a rather large number of measured expression val-
ues of a predeﬁned family of genes (attributes). Each
measurement in the database was extracted from a tissue
of a patient with a speciﬁc disease; this disease is the
class for the given example. The standard goal of ma-
chine learning is to start from such available labeled
examples and construct classiﬁers that can successfully
classify new, previously unseen examples. Such classiﬁ-
ers are important because they can be used for diagnos-
tic purposes in medicine and because they can help to
understand the dependencies between classes (diseases)
and attributes (gene expression values).
The problem of ﬁnding disease markers (classiﬁers)
from gene expression data by machine learning algo-
rithms is characterized by the abundance of attributes
(simultaneously measured gene expression values), and
the shortage of the available examples (patients subject
to measurements). The application of machine learning
algorithms in a domain characterized by a large number
of attributes typically calls for some dimensionality
reduction, even if the employed strategy can in principle
directly accept all the available attribute values. The ben-
eﬁts of prior elimination of irrelevant (or weakly relevant)
attributes in data preprocessing has been recognized in
machine learning [35]: besides helping to reduce the prob-
lem complexity and the computation time, it can enable
the construction of more accurate classiﬁers.
From the dimensionality point of view, the gene
expression domain is speciﬁcally unfavorable, because—
as we have mentioned—the abundance of attributes is
confronted with a relatively small number of available
examples. It is known from the machine learning and sci-
entiﬁc discovery literature that such domains are prone to
overﬁtting: overﬁtted classiﬁers are characterized by sig-
niﬁcantly decreased predictive accuracy on unseen sam-
ples compared to the training set accuracy, or—in other
words—by a high generalization error [14]. See [21] for
an extensive treatment of diﬀerent eﬀects of overﬁtting.
Informally, in domains characterized by a small number
of examples and a large number of attributes, overﬁtting
occurs because some artifacts (ﬂukes) of actually irrele-
vant attribute combinations can emerge simply by means
of chance and appear signiﬁcant with respect to the exam-
ples available to a machine learning algorithm.
To avoid the overﬁtting pitfall, state-of-the-art ap-
proaches construct complex classiﬁers that combine rel-
atively weak contributions of up to thousands of genes
(attributes) to classify a disease [20,45,10,36]. Predictor
robustness is achieved by the redundancy of classiﬁers,
realized, e.g., by voting of multiple classiﬁers. For exam-
ple, [20] use weighted voting of informative genes,
[45,10] employ the support vector machine (SVM) para-
digm, while in [36] scores of top ranked emerging pat-terns are used. The achieved prediction quality on
independent test sets are very high but a drawback of
classiﬁers based on many attributes is that they are not
appropriate for expert interpretation. Although it is pos-
sible to extract the attributes with maximal voting
weight (in [45] such genes are called disease markers
and some of them are already identiﬁed as useful in rou-
tine clinical practice), the logical connections among the
extracted attributes are lost and the construction of ex-
pert comprehensible (disease) models remains a very dif-
ﬁcult task.
This paper describes an approach to the detection of
rules for the classes of gene expression samples that are
much more convenient for expert interpretation, taking
gene expression data modeling as a novel challenge for
the application of the recently developed subgroup dis-
covery methodology [19]. Its goal is the induction of
classiﬁers in the form of explicit short rules describing
important subgroups of the target class samples,
although these simple classiﬁers may be of a lower pre-
dictive quality than the more complex classiﬁers. In-
duced rules typically include 2–5 gene expression
attributes and, in contrast to markers obtained from
voting schemes, these rules explicitly stress the impor-
tance of the correlation of the activity (or non-activity)
of genes in the selected set of attributes. The problem
with the induction of low dimensional, non-redundant
classiﬁers is that they are prone to overﬁtting the train-
ing set. The selection of an appropriate hypothesis lan-
guage as well as the reduction of the hypothesis search
space are known methods for avoiding overﬁtting [46].
Handling overﬁtting by relevancy based feature and rule
ﬁltering are important aspects of this work. In rule
learning, the problem of this approach is that with a
strongly reduced hypothesis space it may be diﬃcult to
induce rules that cover all/many examples from the
training set. However, the proposed subgroup discovery
approach provides a much better framework for the
application of the suggested methodology of feature
and rule relevancy than the standard separate-and-con-
quer rule learning [18].
To arrive at simple rule-based predictors, the numeric
microarray data are discretized, i.e., represented by
means of categorical values. This admittedly introduces
a superﬂuous degree of freedom in the choice of the dis-
cretization threshold values. We adhere to what is
apparently the most natural choice—the discretization
provided by Aﬀymetrix, the microarray manufac-
turer—and it is part of our study to test whether inter-
esting knowledge can be discovered with such
discretized data. Naturally, by selecting this approach
the risk of overﬁtting, potentially leading to rules that
do not reﬂect genuine dependencies between classes
and gene activity values, is not automatically avoided.
The paper outline is as follows. In Section 2, the sub-
group discovery approach is presented, together with
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cusses the results obtained on two publicly available
gene expression problem domains. Expert interpretation
of a subset of rules with high predictive value conﬁrmed
on independent test sets is provided in Section 4, show-
ing the signiﬁcance of the discovered relationships.2. The subgroup discovery methodology
This section presents the subgroup discovery method-
ology1 originally introduced in [19]. Subgroup discovery
is a form of supervised inductive learning of subgroup
descriptions of a given target class. The descriptions
have the form of rules built as logical combination of
features. Features are logical conditions that have values
true or false, depending on the values of attributes which
describe the examples of the given problem domain.
Subgroup discovery rule learning is therefore a type of
two-class attribute based (zero order) inductive learning.
Multi-class problems can be solved as a series of two-
class problems, so that in each run one class is selected
as the target class while examples of all other classes
are treated as non-target class cases.
There is a large body of previous research on rule
induction in machine learning and data mining, and
on subgroup discovery in general. We refer the reader
to the mentioned source [19] explaining how the SD
algorithm relates to similar algorithms, such as classiﬁ-
cation [11,38] and association [2,25] rule learners and
subgroup discovery systems [31,54].
For the purpose of the induction of subgroup
descriptions for gene expression datasets, the system
has been enhanced to be able to accept datasets with a
larger number of attributes. For performing applica-
tions in gene expression data analysis, additional tech-
niques for handling overﬁtting have been implemented,
described in detail in this section.
2.1. An outline of the subgroup discovery approach
Subgroup discovery [54,19] has the goal to uncover
characteristic properties of population subgroups by
building short rules which are highly signiﬁcant (assur-
ing that the distribution of classes of covered instances
are statistically signiﬁcantly diﬀerent from the distribu-
tion in the training set) and have a large coverage (cov-
ering many target class instances).
In this work, subgroup discovery is performed by the
SD algorithm, a relatively simple iterative beam search
rule learning algorithm [19]. The SD input consists of a1 The approach has been implemented in the on-line Data Mining
Server (DMS), publicly available at http://dms.irb.hr. DMS and its
constituting subgroup discovery algorithm SD can be tested on user
submitted domains with up to 250 examples and 50 attributes.set of examples E (E = P [ N, P is the set of target class
examples and N the set of non-target class examples)
and the set of features F that are constructed for the given
example set. For discrete (categorical) attributes, features
have the formAttribute = value orAttribute „ value, while
for continuous (numerical) attributes they have the form
Attribute > value or Attribute 6 value. The output of the
SD algorithm is a set of rules with optimal covering prop-
erties on the given example set. As in classiﬁcation rule
learning, an induced rule (subgroup description) has the
form of a (backwards) implication: Class‹ Cond. In
terms of rule learning, the property of interest for sub-
group discovery is the target class (Class) that appears
in the rule consequent, and the rule antecedent (Cond.)
is a conjunction of features (attribute–value pairs) se-
lected from the features describing the training instances.
In the SD algorithm, subgroups are described by rules
formed of conjunctions of a small number of features.
Each rule describing a subgroup is extended with the
information about the rule qualitywhich enables the eval-
uationof induced rules. Theoutput rule form is as follows:
Class Cond½Sens; Spec;
where Class is the target property of interest, Cond. is a
conjunction of features, Sens is the sensitivity or true po-
sitive rate, i.e., the fraction of positive cases that are cor-
rectly classiﬁed as positive, computed as |TP|/|P|, and
Spec is the speciﬁcity or true negative rate, i.e., the frac-
tion of negative cases correctly classiﬁed as negative,
computed as |TN|/|N|, for TP and TN being the sets of
true positives (target class examples covered by a rule)
and true negatives (non-target class examples not cov-
ered by the rule), respectively. Non-target class examples
covered by the rule are called false positives, FP, and
N = TN [ FP.
Features, formed of attribute–value pairs, are con-
structed in the preprocessing step of the SD algorithm.
To formalize the feature construction procedure, let val-
ues vix (x = 1, . . .,kip) denote the kip diﬀerent values of
attribute Ai that appear in the target class examples
and wiy (y = 1, . . .,kin) the kin diﬀerent values of Ai
appearing in the non-target class examples. A set of fea-
tures F is constructed as follows:
 For discrete attributes Ai, features of the form
Ai = vix and Ai „ wiy are generated.
 For continuous attributes Ai features of the form
Ai 6 (vix + wiy)/2 are created for all neighboring value
pairs (vix,wiy), and features Ai > (vix + wiy)/2 for all
neighbor pairs (wiy,vix).
2.2. Handling overﬁtting
There is no ideal solution to the problem of
data overﬁtting. No inductive learning algorithm can
2 See Table 1 to see how the do not know value M is handled in the
preprocessing of the SD algorithm.
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training set. There are two main mechanisms that can
be used to avoid overﬁtting.
 Overﬁtting can be reduced if the hypothesis search
space is suitably restricted [14].
 In rule learning, the standard approaches to handling
the problem of overﬁtting is through the use of
appropriate search heuristics and stopping criteria
used in rule construction, stopping criteria used in
ruleset construction and rule truncation. For exam-
ple, most separate-and-conquer based rule learners
[18] (e.g., AQ, CN2, RIPPER, and CLASS) use heu-
ristics aimed at maximizing rule accuracy. To avoid
overﬁtting, these systems are capable of learning im-
pure rules with increased rule coverage (generality).
Accordingly, we implement both of these mechanisms
in the employed subgroup discovery methodology.
 The hypothesis search space is restricted in three
ways: through domain speciﬁc restrictions for feature
construction for functional genomics domains, out-
lined in Section 2.3, ﬁltering of irrelevant features
described in Section 2.4 and ﬁltering of irrelevant
rules described in Section 2.5. In the implementation
of these mechanisms, cautiousness is needed as strong
restrictions of the hypothesis search space may pre-
vent ﬁnding all the important rules. An equally
important part of the methodology for avoiding over-
ﬁtting is that each feature that enters the subgroup
discovery process should itself be a relevant target
class descriptor.
 Increased rule coverage, resulting in rules covering
also non-target class examples, is achieved in the
SD subgroup discovery algorithm by using the fol-
lowing rule quality measure in heuristic search: |TP|/
|(FP| + g), where g is a user deﬁned generalization
parameter. High quality rules will cover many target
class examples and a low number of non-target exam-
ples. The number of tolerated negative examples, rel-
ative to the number of covered target class cases, is
determined by parameter g. The SD beam search rule
learning algorithm is described in Section 2.6.
2.3. Domain speciﬁc feature construction
Gene expression scanners measure signal intensity as
continuous values which form an appropriate input for
data analysis. The problem is that for continuous valued
attributes there can be potentially many boundary val-
ues separating the classes, resulting in many diﬀerent
features for a single attribute. There is also a possibility
to use presence call (signal speciﬁcity) values computed
from measured signal intensity values by the AﬀymetrixGENECHIP software. The presence call has discrete
values A (absent), P (present), and M (marginal). The
M value can be interpreted as a do not know state
and for the remaining values A and P it holds that fea-
ture Attribute = A is identical to Attribute „ P; conse-
quently, for every attribute there are only two distinct
features Attribute = A and Attribute = P generated for
each gene.2
Signal intensity values are most frequently used [36]
because they impose less restrictions to the classiﬁer con-
struction process and because the results do not depend
on the GENECHIP software presence call computation.
In the subgroup discovery approach, we prefer the use
of presence call values. The reason is that features pre-
sented by conditions like gene Ai is present or gene Aj
is absent are very natural for human interpretation.
Although the GENECHIP software presence call com-
putation may not be ideal, expert evaluation of the re-
sults demonstrates that it can enable induction of very
interesting rules both because of the ease of their inter-
pretation and because of their predictive quality.
A more important reason for using presence call val-
ues is that the approach can help in avoiding overﬁtting,
as the feature space is very strongly restricted: instead of
many features per attribute we have only two. Also, as
the measured gene expression values are not completely
reliable (which is reﬂected by the fact that for the same
sample measured values may change from one measure-
ment to another), some robustness of constructed rules
is welcome. To some extent, this can be achieved by
treating the marginal presence call attribute value M
as a do not know state. The value can neither be used
to support the relevancy of a feature or a rule, nor can
it be used for prediction purposes. In this way, it addi-
tionally restricts the hypothesis search space.
A drawback of this approach is that we depend on
the GENECHIP software presence call computation
which can change with time. However, the SD method-
ology is general in the sense that it can accept as its input
either A/P/M values computed by any software, or real
signal intensity values.
With respect to the feature construction process, the
following observations are worth reﬂecting on. The fea-
tures are restricted to simple forms only, as deﬁned in
Section 2.1, because their complex forms may enable
that, despite testing feature covering properties, features
with insuﬃcient supportive evidence may enter the rule
construction process. For example, for discrete attri-
butes the simple features have the form Ai = a or
Ai „ a. No complex logical forms like (Ai = a  Aj = b)
or (Ai = a  Aj = b) are acceptable. The ﬁrst form is
not needed as all potential conjunctions are tested by
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algorithm. The second form is dangerous because, for
example, the feature Ai = a may be relevant while the
feature Aj = b may be irrelevant. Their combination
Ai = a  Aj = b may be even more relevant than Ai = a
itself, which may cause that condition Aj = b may be in-
cluded into the ﬁnally constructed rules while its inclu-
sion is not justiﬁed by its covering properties on the
training set. Notice that if both conditions Ai = a and
Aj = b are relevant, it does not mean that by restricting
the form of used features some important logical combi-
nations of features will be ignored. In the subgroup dis-
covery approach, both features can build separate
subgroup descriptions and—if they are relevant—they
both have a chance to appear in the ﬁnal set of induced
rules.
2.4. Feature ﬁltering
Features are elementary ingredients of rules. But indi-
vidual features are short rules themselves. The quality of
a feature is determined by its covering property on the
training set. This section presents the methodology en-
abling the detection and elimination of irrelevant fea-
tures which signiﬁcantly helps in reducing the
hypothesis space. More importantly, the methodology
ensures that only relevant features will enter the process
of rule construction which is important for avoiding
overﬁtting. Although this section mentions only feature
ﬁltering, the same methodology is applicable to any log-
ical combination of features, including the complete
rules.
Deﬁnition 1. (Total irrelevancy.) A feature that has
either |TP| = 0 or |TN| = 0 is totally irrelevant.
If a feature has |TP| = 0 or |TN| = 0 it is totally
irrelevant because it is of no use in building rules that
distinguish one class from the other. A gene is called
constant-valued gene if it has, besides some M values,
either only A or only P values for all examples in the
training set. Both features generated from a constant-
valued attribute are totally irrelevant because they either
have |TP| = 0 or |TN| = 0. Table 1 presents a constant-
valued attribute and the features generated for the
given attribute. In the experiments presented inTable 1
A table illustrating ﬁve positive and four negative examples for a given target
both features X = A and X = P are totally irrelevant
Target class samples
M A A A
Gene X
Feature X = A False True True True
Feature X = P False False False False
The ﬁrst has |TN| = 0 while the second has |TP| = 0.Section 3, the number of detected constant valued attri-
butes eliminated in preprocessing was between 12 and
40%.
In the example in Table 1, it can be also noticed that
feature f has value false for the attribute value M when
the example is in the target class and value true when the
example is in the non-target class. It means that for an
example with attribute value M, feature truth-values
do not depend on the properties of the feature but on
the class to which the example belongs.
While total irrelevancy helps in reducing the compu-
tational complexity of the machine learning task, the
main goal of applying absolute feature irrelevancy is
to ensure a minimal quality of features which are used
in the rule induction process.
Deﬁnition 2. (Absolute irrelevancy.) A feature that has
either |TP| < min_tp or |TN| < min_tn is absolutely
irrelevant, where min_tp and min_tn are user deﬁned
constraints.
A feature with |TP| < min_tp is true for a small num-
ber of target class examples and a feature with
|TN| < min_tn is false for a small number of non-target
class examples. It is assumed that such small numbers
may be due to statistical chance so that it seems reason-
able not to use features with either of these properties in
the rule construction process. Through a conjunctive
connection of features, the generated rule will have
|TP| smaller or equal than the smallest |TP| value of
the features forming the subgroup description. In con-
trast, the rule |TN| value will be at least as large as the
largest |TN| of the used features. This is the reason
why min_tp is typically larger than min_tn and it can
be as large as the minimal estimated number of samples
that must be covered by any acceptably good subgroup
for the domain.
The problem with absolute irrelevancy is that both
min_tp and min_tn are user deﬁned constants. Optimal
values for these constants may signiﬁcantly change from
one application to another. A practical suggestion is to
start with small values of these constants and experi-
ment by increasing the values. Our experience in gene
expression domains suggests to choose min_tp = |P|/2
and min tn ¼ ﬃﬃﬃﬃﬃﬃjN jp as the starting values; these
values have been used in all the experiments reportedclass (the selected cancer type) in which gene X is constant-valued and
Non-target class samples
A A A M A
True True True True True
False False False True False
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absolutely irrelevant features was between 50 and 75%.
While the aim of using absolute relevancy is to ensure
a minimal quality that must be satisﬁed by every feature,
relative relevancy should ensure that only the best
among the available features will enter the rule construc-
tion process.
Deﬁnition 3. (Relative irrelevancy.) Feature f is irrele-
vant if there exists another feature frel such that true
positives of f are a subset of true positives of frel,
TP( f ) ˝ TP( frel), and true negatives of f are a subset of
true negatives of frel, TN( f ) ˝ TN(frel).
If for feature f there exists another feature frel with the
property that if in any rule f is substituted by frel, the
rule quality measured by the number of correct classiﬁ-
cations on the example set does not decrease, then it
means that frel can be always used instead of f, and that
we actually do not need f. Relative irrelevancy is very
useful because it does not depend on user deﬁned thresh-
old values and its usage is suggested for all machine
learning approaches [34].
If genes are described by A, P, and M values and if
there are two genes with identical values for all training
examples then one of them can be eliminated as irrele-
vant because the features based on this gene have the
same covering properties as the features based on the
other gene. If two genes X and Y do not have identical
values for all examples then if it happens that one of
the features of X is irrelevant because of the feature con-
structed as a condition of gene Y then the other feature
of X may not be irrelevant because of the other feature
of Y. But this property does not mean that attributes
can be eliminated only if there exists another attribute
with identical values; there can exist another gene Z
whose feature will make the second feature of X irrele-
vant and make the complete attribute X irrelevant as
well. This is demonstrated by an example in Table 2.
It is also possible that the second feature is absolutely
irrelevant because of a small |TP| or |TN| value.Table 2
An example in which gene X is relatively irrelevant because its feature X = A
relatively irrelevant because of feature Z = A
Target class samples
A P A P
Gene X
Feature X = A True False True False
Feature X = P False True False True
Gene Y A P A P
Feature Y = A True False True False
Feature Y = P False True False True
Gene Z A A P A
Feature Z = A True True False True
Feature Z = P False False True FalseIn cases when continuous gene expression values are
used, the same conditions for feature relevancy are
applicable. But there are many features constructed
from a single gene and all of them must be detected as
irrelevant in order that a complete gene is eliminated be-
cause of its irrelevancy.
In the experiments presented in Section 3, the process
of identifying relative irrelevancy eliminated between 65
and 85% of features. Most of them are detected also as
absolutely irrelevant features. By the combination of the
conditions for absolute and relative irrelevancy it was
possible to eliminate 70–90% of features that remained
after the elimination of totally irrelevant features. The
importance of the approach is that the remaining fea-
tures satisfy some predeﬁned quality (determined by
the absolute relevancy condition), and more impor-
tantly, that they are the best features for the domain
(according to the relative relevancy criterion).
The reader may wonder why the preselection of fea-
tures is done in a univariate way. At a ﬁrst glance it
may seem possible that two feature having the TP and
TN properties of a coin toss when viewed in isolation ex-
hibit strong predictive power in combination (as is the
case in predicting x-or). It can easily be shown that if
feature f is relatively irrelevant because of feature frel
and feature g is relatively irrelevant because of feature
grel, then f  g is relatively irrelevant because of frel  grel.
This claim can be veriﬁed by ﬁrst ﬁxing one of the two
conjuncts, e.g., grel = g and showing that in this case
TP( f  g) ˝ TP( frel  g) and TN( f  g) ˝ TN( frel  g).
Next, the same relationship can be shown also for the
case when g is relatively irrelevant because of grel. Con-
sequently, if for feature f there exists another feature frel
with the property that if in any rule f is substituted by frel
the rule quality measured by the number of correct clas-
siﬁcations |TP| and |TN| does not decrease, then it means
that frel can be always used instead of f, and that we
actually do not need f. This means that f can be elimi-
nated as irrelevant. Hence, the ﬁltering of relatively irrel-
evant features will not hinder the construction of
relevant conjuncts.is relatively irrelevant because of feature Y = A, and its feature X = P is
Non-target class samples
M A P M P
False True False True False
False False True True True
A P P M P
True False False True False
False True True True True
A P P A A
True False False True True
False True True False False
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Any rule induced by the SD algorithm must have at
least a minimal support.3 Minimal acceptable support
for a domain is deﬁned by the user deﬁned min_support
parameter (see the SD algorithm in Section 2.6). If a
subrule of a rule (a subset of features forming the rule)
does not satisfy this condition then the rule as a whole
does not satisfy it either. Therefore, this condition is
built into the iterative loop of the SD algorithm and
every partial solution of best features which does not
satisfy this condition cannot be kept in the beam. Be-
sides restricting the search space, this requirement en-
ables shorter algorithm execution time. The default
value for the parameter min_support is equal toﬃﬃﬃﬃﬃﬃjP jp =jEj, but for the gene expression data it can be as
high as |P|/2|E|. The min_support condition is tested in
step 7 of the SD algorithm described in Section 2.6.
High conﬁdence4 of induced rules is ensured by the
deﬁnition of rule quality qg used in the search process
of the SD algorithm (Section 2.6) which prefers rules
with large |TP| and small |FP|. Although the length of in-
duced rules is not limited, the approach ensures the con-
struction of short rules; the reason is that conjunctions
of features have the property that the number of target
class examples covered by adding a conjunct to a con-
junction of features decreases. Long conjunctive rules
have a very small chance to satisfy the minimal support
condition and to be optimal with respect to rule quality
qg at the same time. In the experiments, all the induced
rules have up to four features while all those explicitly
shown in this paper and analyzed by the domain expert
have only two features. This is very favorable because
the complexity of the hypothesis space is signiﬁcantly re-
stricted and enables easy expert analysis.
2.6. Algorithm SD
The goal of the subgroup discovery algorithm SD,
outlined in Fig. 1, is to search for rules that maximize
rule quality measure qg ¼ jTP jjFP jþg. High quality rules cover
many target class examples and a low number of non-
target examples. The user can express his preferences
about rule generality (how many target class cases are
covered by the rule description) in respect to the rule
speciﬁcity (how many non-target class cases are covered
by the rule) by selecting the parameter g. For low g val-
ues (g 6 1), induced rules will have high speciﬁcity since
every false positive classiﬁcation is made relatively very
expensive. On the other hand, by selecting a high g3 Support is the number of correctly classiﬁed target class samples
divided by the total number of samples, |TP|/|E|.
4 Conﬁdence (also called precision) is the fraction of all samples
classiﬁed into the target class that actually belong to the target class,
|TP|/(|TP| + |FP|).value (g > 10 for small domains), more general rules will
be generated which can have also many false positive
predictions. Suggested g values in the SD algorithm in
the Data Mining Server are in the range between 0.1
and 100, for analyzing data sets of up to 250 examples.
In addition to parameters g and min_support, the SD
algorithm has an additional parameter which is deﬁned
by the user, but which does not need to be adjusted fre-
quently. The beam_width parameter (default value is 100
for gene expression domains) deﬁnes the number of
solutions kept in the beam in each iteration. The output
of the algorithm is set S of beam_width diﬀerent rules
with highest qg values. In the described experiments,
we have used only the ﬁrst (best) solution although there
is a possibility to select a few relatively diﬀerent solu-
tions using the algorithm described in [19], or to enter
the expert evaluation process with a set of a few best
rules, letting the experts select the optimal solution(s).
Moreover, the rules from set S could be used as an input
to a redundant voting classiﬁer, but this variant is out of
the scope of this work.
The algorithm initializes all the rules in Beam and
New_beam by empty rule conditions. Their quality val-
ues qg(i) are set to zero (step 1). Rule initialization is fol-
lowed by an inﬁnite loop (steps 2–12) that stops when,
for all rules in the beam, it is no longer possible to fur-
ther improve their quality. Rules can be improved by
conjunctively adding features from F. After the ﬁrst iter-
ation, a rule condition consists of a single feature, after
the second iteration up to two features, and so forth.
The search is systematic in the sense that for all rules
in the beam (step 3) all features from F (step 4) are tested
in each iteration. For every new rule, constructed by
conjunctively adding a feature to rule body (step 5),
quality qg is computed (step 6). If the support of the
new rule is greater than min_support and if its quality
qg is greater than the quality of any rule in New_beam,
the worst rule in New_beam is replaced by the new rule.
The rules are reordered in New_beam according to their
quality qg. At the end of each iteration, New_beam is
copied into Beam (step 11). When the algorithm termi-
nates, the ﬁrst rule in Beam is the rule with maximum qg.
A necessary condition (in step 7) for a rule to be in-
cluded in New_beam is its relative relevancy. A new rule
is irrelevant if there already exists a rule R in New_beam
such that true positives of the new rule are a subset of
true positives of R and true negatives of the new rule
are a subset of true negatives of R (in the same way as
relative feature irrelevancy described in Section 2.4).
After the new rule is included in New_beam it may hap-
pen that some of the existing rules in New_beam become
relatively irrelevant with respect to this new rule. Such
rules are eliminated from New_beam during its reorder-
ing (in step 8). The testing of relevancy ensures that
New_beam contains only diﬀerent and relatively relevant
rules.
Fig. 1. Heuristic beam search rule construction algorithm for subgroup discovery.
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In this section, we present results obtained by apply-
ing the subgroup discovery methodology in two gene
expression problem domains.
 The ﬁrst is the problem of distinguishing between
acute lymphoblastic leukemia (ALL) and acute mye-
loid leukemia (AML) described in [20]. Here, a train-
ing set with 38 samples (27 of type ALL and 11 of
type AML) and a test set with 34 samples (20 of type
ALL and 14 of type AML) have been available.
Every sample is described by expression values of
7129 genes.
 The second domain is the multi-class cancer diagnosis
problem for 14 diﬀerent cancer types described in
[45]. It has 144 samples in the training set and 54 sam-
ples in the test set. Every sample is described by
expression values of 16,063 genes, where the ﬁrst
7129 genes are the same as in the leukemia problem.
Training and test data sets, together with the descrip-
tion ﬁles, can be downloaded from http://www-
genome.wi.mit.edu/cgi-bin/cancer/datasets.cgi. Given
the shortage of examples in gene expression problem do-
mains, some sources suggest to use the so-called permu-
tation test to assess the classiﬁer accuracy, rather than
isolating an independent test set. It has been shown in
[23], however, that this alternative does not bring an
advantage over the traditional accuracy estimation to
which we thus adhere. Also note that a common tech-
nique known as leave-one-out cross-validation [21]
would be a natural assessment choice when examples
are rare. However, we have chosen to use the train/testdata splits provided by [20] and [45], respectively, to
be able to fairly compare our results with theirs.
Subgroup discovery starts from the available training
sets with pre-computed presence call values. As de-
scribed in Section 2.3, feature set F is very simple: it con-
sists only of features Attribute = A (gene expression
absent) and Attribute = P (gene expression present) gen-
erated for non-constant attributes. Features covering
fewer than min_tp = |P|/2 target class examples or fewer
than min tn ¼ ﬃﬃﬃﬃﬃﬃjN jp non-target class examples as well as
all relatively irrelevant features have been eliminated in
preprocessing of the SD algorithm. The user selected
constants for the SD algorithm have been min_sup-
port = min_tp = |P|/2 and beam_width = 100. Selection
of these four constants is not critical: any beam_width
value larger than 100 and any min_support, min_tp,
and min_tn value up to 50% lower than the mentioned
values result in the induction of same subgroups. The
only observable consequence is the increase of the SD
algorithm execution time.
3.1. The AML/ALL leukemia domain
For the ﬁrst domain, 2844 attributes have been de-
tected as totally irrelevant. After the elimination of
absolutely and relatively irrelevant features, 639 relevant
features remained when ALL is the target class and 622
when AML is the target class. For all generalization
parameter values in the range 0.1–50 the SD algorithm
has in both cases consistently constructed the same best
subgroups shown in Table 3.
Table 4 presents the prediction results measured on
the training set, independent test set, and on an indepen-
dent test set consisting of leukumia samples from the
Table 3
Rules induced for the leukemia domain for classes acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL)
Models for the AML/ALL leukemia domain
AML class ‹
(LEPR_leptin_receptor EXPRESSED) AND (glutathione_s_transferase_microsomal EXPRESSED)
ALL class ‹
(DF_D_component_of_complement_(adipsin) NOT EXPRESSED) AND (liver_mRNA_interferon_gamma_inducing_factor NOT
EXPRESSED)
To improve the interpretability of induced models, gene values P and A have been replaced by EXPRESSED and NOT EXPRESSED, respectively.
Table 4
Sensitivity and speciﬁcity values for the leukemia training and test set, as well as for the leukemia samples from the multi class problem
Cancer Training set Test set Leukemia from multi-class domain
Sens. Spec. Sens. Spec. Precision (%) Sens. Spec. Precision (%)
AML 11/11 27/27 9/14 18/20 82 7/10 19/20 87
ALL 26/27 11/11 19/20 13/14 95 8/20 10/10 100
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although the rules have good sensitivity and speciﬁcity
values5 on the training set, the measured prediction
quality on the test sets is not as good. Especially sensitiv-
ity values are not satisfactory because they are as low as
40% for the ALL rule tested on the multi-class leukemia
test set. Interestingly, measured speciﬁcity values are
much better and the lowest value 90% is measured for
the AML rule on the two-class test set. Compared to
the results reported in [20] our ﬁgures are slightly lower
than those obtained by a weighted voting approach. Dif-
ferences between results obtained on the training set and
measured on the test sets, as well as diﬀerences among
results obtained on diﬀerent test sets indicate that some
overﬁtting took place in spite of the implemented tech-
niques of hypothesis space restriction. Although the
rules are not that good for diagnostic purposes, i.e., dis-
tinguishing between AML and ALL disease types, in-
duced rules describe some relevant—although smaller
than expected—subgroups of disease classes. Their most
signiﬁcant quality is their easy interpretability as shown
by the expert evaluation in Section 4.1.
3.2. The multi-class cancer domain
The same procedure was repeated for the second do-
main. For each cancer type as the target class, a rule
(subgroup description) was constructed so that all other
cancer types were treated as non-target class examples.
In preprocessing, 2000 out of 16,063 attributes were de-
tected as totally irrelevant. After the elimination of
absolutely and relatively irrelevant features, for diﬀerent
classes 3300–8500 relevant features remained which in
average presents 28% of all constructed features. The5 In Tables 4 and 5, sensitivity and speciﬁcity values are presented
as fractions with the denominators presenting the numbers of positive
and negative examples on which the rule quality has been tested.SD algorithm was used for all classes with the general-
ization parameter g equal to 5. Table 5 presents the sen-
sitivity and the speciﬁcity results for the training set and
the available independent test set. Additionally, the
measured precision value is computed for the test set.
From Table 5, an interesting and important relation-
ship between prediction results on the test set and the
number of target class examples in the training set can
be noticed. The obtained prediction quality on the test
set is very low for many classes, signiﬁcantly lower than
those reported in [45]. For 7 out of 14 classes the mea-
sured precision is 0%. However, there are very large dif-
ferences among the results for various classes (diseases).
It can be noticed that the precision on the test set higher
than 50% has been obtained for only 5 out of 14 classes.
There are only three classes (lymphoma, leukemia, and
CNS) with more than eight training samples and for
all of them the induced rules have high precision on
the test set, while for only 2 out of 11 classes with eight
training cases (colorectal and mesothelioma) a high pre-
cision has been achieved. The classiﬁcation properties
corresponding to classes with 16 and 24 target class
examples are comparable to the performances reported
for these classes in [45], yet achieved by predictors much
simpler than in the mentioned work. Consequently, we
select those for expert interpretation in Section 4.2.
The results indicate that there is a certain threshold
on the number of available training examples below
which the subgroup discovery algorithm SD is not
appropriate because it can not prevent overﬁtting de-
spite the techniques designed for this purpose.6 How-
ever, it seems that for only slightly larger training sets6 Improved results could be achieved by voting of best rules induced
in several runs of the SD algorithm within the DMS covering
algorithm; this work is out of the scope of this paper, as voting of
numerous classiﬁers would hinder the interpretability of induced
descriptions.
Table 7
The AML/ALL domain: comparing predictive accuracy and the
number of involved genes for predictors obtained by the subgroup
discovery approach (SD), by support vector machine construction
(SVM), and by voting of informative genes [20]
Cancer Classiﬁer Accuracy (%) No. of genes
AML SD 79.41 2
SVM I [10] 88.24 50
Voting [20] 93.94 50
ALL SD 94.11 2
SVM II [10] 94.11 50
SVM III [10] 97.05 50
The three versions of SVM correspond to three groups of predictors
with diﬀerent parameterizations and diﬀerent gene sets employed, as
reported by [10].
Table 5
Prediction results measured for 14 cancer types in the multi-class domain
Cancer Training set Test set
Sens. Spec. Sens. Spec. Precision (%)
Breast 5/8 136/136 0/4 49/50 0
Prostate 7/8 136/136 0/6 45/48 0
Lung 7/8 136/136 1/4 47/50 25
Colorectal 7/8 136/136 4/4 49/50 80
Lymphoma 16/16 128/128 5/6 48/48 100
Bladder 7/8 136/136 0/3 49/51 0
Melanoma 5/8 136/136 0/2 50/52 0
Uterus_adeno 7/8 136/136 1/2 49/52 25
Leukemia 23/24 120/120 4/6 47/48 80
Renal 7/8 136/136 0/3 48/51 0
Pancreas 7/8 136/136 0/3 45/51 0
Ovary 7/8 136/136 0/4 47/50 0
Mesothelioma 7/8 136/136 3/3 51/51 100
CNS 16/16 128/128 3/4 50/50 100
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clusion is very optimistic because we can expect signiﬁ-
cantly larger gene expression databases to become
available in the near future.
Table 6 presents the rules for the three cancer types
with 16 and 24 training samples. Expert analysis of these
rules in presented in Section 4.2. For all three diseases, a
very good agreement in prediction results for the train-
ing and the test set can be noticed, which indicates that
no signiﬁcant training data overﬁtting has occurred. The
sensitivity values measured on the test set are between 66
and 83% while the speciﬁcity value is always excellent
and equal or almost equal to 100%, for all the three
rules.
3.3. Comparing classiﬁcation performance to previous
results
We now relate the predictive classiﬁcation perfor-
mance of the ﬁve selected rules (2 for the AML/ALL do-
main and 3 for the multi-class domain) obtained by
subgroup discovery to predictors for the corresponding
classes previously reported in [20,45,10]. Due to diﬀer-
ences in the presentation of predictive performance indi-
cators in the mentioned literature, we convert them into
a uniﬁed quantity of predictive accuracy, deﬁned as the
proportion of correctly classiﬁed testing instancesTable 6
Rules induced for the multi-class cancer domain for cancer types with 16 (ly
Models for the multi-class cancer domain
lymphoma class ‹
(CD20_receptor EXPRESSED) AND (phosphatidyl-inositol_3_kinase_reg
leukemia class ‹
(KIAA0128_gene EXPRESSED) AND (prostaglandin_d2_synthase_gene
CNS class ‹
(fetus_brain_mRNA_for_membrane_glycoprotein_M6 EXPRESSED) ANamong all testing instances. Further, we observe the
number of genes (attributes) employed in the individual
predictors.
The results for the AML/ALL domain are summa-
rized in Table 7. We now describe the way we calculated
the classiﬁcation accuracy. For the subgroup discovery
algorithm, we have two rules, each obtained by viewing
one of the classes as the target class. To assess predictive
accuracy, the two rules can be combined into a single
two-class classiﬁer, for example by a voting mechanism
supplemented by a majority-class vote for instances not
complying to the conditions of any of the rules. Such amphoma and CNS) and 24 (leukemia) target class samples
ulatory_alpha_subunit NOT EXPRESSED)
NOT EXPRESSED)
D (CRMP1_collapsin_response_mediator_protein_1 EXPRESSED)
Table 8
Multi-class cancer domain: Comparing predictive accuracy and
number of involved genes for selected predictors obtained by the
subgroup discovery approach (SD) and by support vector machine
(SVM) construction [45]
Class Classiﬁer Accuracy (%) No. of genes
Lymphoma SD 98.14 2
SVM [45] 100.00 16063
Leukemia SD 94.44 2
SVM [45] 98.14 16063
CNS SD 98.14 2
SVM [45] 100.00 16063
7 A subclass of white blood cells.
8 Blood forming.
9 A secreted signaling peptide (protein).
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ment of simplicity. Therefore, we rather view each of
the two rules as an individual binary classiﬁer, inter-
preted under the closed-world assumption. That is, if
the AML rule antecedent is not satisﬁed, then ALL is
considered as the predicted class. The inverse principle
is applied for the ALL rule. Each of the two rules is thus
assigned its own accuracy value.
To calculate the predictive accuracy of the voting ap-
proach in [20], we consider that their predictor provided
a class decision in 29 of the 34 testing cases and this deci-
sion was always correct. For the ﬁve undecided cases, we
consider the accuracy of the majority vote on the test set
(20
34
¼ 58:82%). The overall accuracy value is thus calcu-
lated as 29
34
100%þ 5
34
58:82% ¼ 93:94%.
Finally, the SVMs in [10] provides a binary decision
for all testing examples, therefore the accuracy calcula-
tion is straightforward using the provided counts of
(in)correct classiﬁcations (Table 3 in [10]).
Two further notes have to be made on the numbers of
genes (attributes) involved in the respective predictors,
as quoted in Table 7. For the voting approach, Golub
et al. [20] report that the number of correct decisions
was maintained at 100% when reducing the number of
employed genes to as low as 10. However, it is not re-
ported for how many cases the reduced classiﬁer was
able to provide a decision. Therefore, we could not cal-
culate the corresponding predictive accuracy value in the
manner described above. For the SVMs in [10], the per-
formance was also measured with the number of em-
ployed genes decreasing to as low as 4, and it was
shown to fall rather quickly (see Table 2 in [10]). For
a 4-best-genes attribute subset, the accuracy ranged
from 54 to 93%, depending on the feature ranking meth-
od and the SVM parameterization. Even these rather
low accuracies reported for the simpliﬁed classiﬁers
probably overestimate the accuracies on the correspond-
ing test sets. This is because they were measured by the
cross-validation procedure combining the training and
test sets for induction purposes and leaving only one
example for testing at each validation stage. Thus, the
assessed predictors were constructed from larger train-
ing sets than the predictors listed in Table 7.
Table 8 compares the predictive performance of the
selected best classiﬁers obtained by the subgroup discov-
ery approach in the multi-class cancer domain, with the
SVM predictors for the corresponding classes achieved
by [45] (see Fig. 4 of their paper). The accuracy for each
class is measured for a binary classiﬁcation task where
all the examples of the given class are treated as positive
and all the other examples as negative. Again, we ob-
serve the number of genes employed in the respective
classiﬁers. Ramaswamy et al. [45] also investigate
whether the predictive accuracy is sensitive to a decreas-
ing number of available attributes (see Fig. 5 in [45]), but
we cannot use these results as they are averaged over allclasses and individual class results are not reported.
However, the fact that the average accuracy of SVM
falls from about 74% for 10,000 genes to about 57%
for 3 genes indicates that—unlike with the SD ap-
proach—satisfactory accuracy can not be expected from
SVM with a very small number of employed attributes.4. Expert evaluation of induced models
This section provides an expert evaluation of the in-
duced subgroup descriptions by one of the authors
(J.T.), who was not involved in the rule discovery pro-
cess described above. To make the text accessible to a
reader without biological background, we provide a less
formal explanation of certain terms. In general, albeit a
simpliﬁed view, cellular processes which increase prolif-
eration (cellular division) and inhibit apoptosis (cellular
death) are consistent with a phenotype of cancerous cell.
4.1. The AML/ALL domain
Cancers which originate from hematopoietic (blood)
cells are called leukemias and lymphomas. Acute leuke-
mias can be of either lymphoid7 origin (acute lympho-
cytic leukemia, ALL) or myeloid7 origin (acute
myelogenous leukemia, AML).
The best-scoring rule for the AML disease class was
the following:
AML class:
(LEPR_leptin_receptor EXPRESSED) AND (glutathi-
one_s_transferase_microsomal EXPRESSED)
The ﬁrst condition assumes the expression of the lep-
tin receptor. The obesity gene product leptin regulates
food intake, but it is also important in the regulation
of inﬂammation, immunity and hematopoiesis8 [16].
The leptin receptor, a single transmembrane-spanning
molecule, is a member of the cytokine9 receptor super-
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[22], and, while absent from samples of ALL, it is fre-
quently expressed in primary and secondary AML
[32]. Interaction of leptin with its receptor has prolifera-
tive and anti-apoptotic eﬀect on AML blasts [32].
Leptin, secreted from bone marrow adipocytes,10 stimu-
lates both myeloid7 development and bone marrow
angiogenesis.11 Furthermore, it has been shown [24] that
inhibition of the leptin receptor signaling by anti-leptin
receptor antibody decreased both microvessel formation
and number of AML blasts in the bone marrow.
Regarding the second condition, Glutathion-S-trans-
ferases (GST) are liver cytosolic12 and microsomal12 en-
zymes, which metabolize toxic substances [28].
Detoxiﬁcation of toxic substances (e.g., environmental
mutagens and chemotherapeutic drugs used in cancer
treatment) is important for both the development of
malignancies and their response to treatment. Whereas
the condition regards the microsomal kind of GST, most
of existing literature and knowledge is concerned with
the cytosolic kind. For example, it is known that cyto-
solic GST are polymorphic in humans and null variants
of some GST isoforms seem to increase oxidative stress
on hematopoietic stem cells. This may in turn lead to a
higher incidence of leukemia or chemotherapy resistant
disease with poorer outcome [53,27,33].
Concerning the possible leptin–GST interaction, it is
remarkable that in a study [4] of experimental hepato-
toxicity with reduced cytosomal GST in a murine model,
exogenous administration of leptin resulted in decreased
detoxiﬁcation and high levels of reactive byproducts.
Again, our model assumes the elevated expression of
microsomal GST and thereby does not directly parallel
the mentioned study. However, it suggests that the lep-
tin receptor and GST may form a combined factor rele-
vant to pathophysiology of AML, and along with [4] it
motivates a further investigation of the possible interac-
tion of leptin with the GST family.
The best-scoring rule for the ALL disease class was
the following:
ALL class:
(DF_D_component_of_complement_(adipsin) NOT
EXPRESSED) AND (liver_mRNA_interferon_gam-
ma_inducing_factor EXPRESSED)
The ﬁrst condition is concerned with adipsin, also
termed complement factor13 D. This is an enzyme pro-10 ‘‘Fat cells’’.
11 Forming of vessels.
12 The adjectives cytosolic and microsomal refer to two diﬀerent
locations within the cell.
13 Substance present in blood that plays role in blood-clotting and
immune response.ducing the acylation14-stimulating protein (ASP),
which increases triglyceride synthesis in adipocytes10
[9]. Adipsin is expressed in cell lines derived from hu-
man monocytes [5], hepatocytes15 [6], astroglioma16
[7] and gastric cancer [30], but not—to our knowl-
edge—in ALL. Signiﬁcantly, a recent analysis of ALL
and AML transcription proﬁling data identiﬁed adipsin
as one out of three best targets for investigating the ba-
sic biology of ALL/AML and their mutual distinction
[10]. Our model thus conﬁrms this basic observation
of [10], but is more informative in that it speciﬁcally
articulates the absence of adipsin expression assumed
for the ALL class.
Interferon-gamma-inducing factor, assumed to be ex-
pressed by the second condition, was discovered in 1995
[43] and later termed interleukin-18 (IL-18). IL-18 is se-
creted by activated macrophages7 and induces high lev-
els of interferon-gamma production in T cells17 [49]. The
rules assumption is compatible with the previous study
[52] where increased IL-18 expression has been corre-
lated with ALL. The expression has been correlated also
with cutaneous18 natural killer lymphoma [3], cutaneous
T-cell lymphoma [3], metastatic breast cancer [37], lym-
phohistiocytosis19 [51], and high risk AML [57]. It has
been suggested that IL-18 could lead to antitumor eﬀects
in some cancers through induction of apoptosis [42], and
that IL-18 is likely involved in the autonomy of leuke-
mic cells [58].
A remark should be made concerning the mutual
relationship of the two genes involved in the rule.
Interferon-gamma has been observed in the human
astroglioma15 cell line to stimulate the expression of
complement factors13 B and C2, closely related to
adipsin (complement factor D) [7]. Adipsin itself,
however, was refractory to the IL-18 stimulation.
This is in agreement with the simultaneous presence
of IL-18 and absence of adipsin as stipulated by
the rule.
4.2. The multi-class cancer domain
Here we discuss the discovered rules for three respec-
tive cancer classes: lymphoma, leukemia, and central
nervous system (CNS) cancers. As we have mentioned
already, leukemias and lymphomas are cancers originat-
ing from hematopoietic (blood) cells.14 Addition of a carbohydrate group.
15 Liver cells.
16 Brain cancer.
17 Thymus-derived white blood cell. The thymus is a gland respon-
sible for maturation of some immune cells.
18 Skin-related.
19 Disease associated with high numbers of histiocytes
(macrophages).
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Lymphoma class:
(CD20_receptor EXPRESSED) AND (phospha-
tidylinositol_3_kinase_regulatory_alpha_subunit NOT
EXPRESSED)
The ﬁrst condition stipulates the expression of the
CD20 receptor. CD20 receptor, a calcium channel,20 is
a lineage-speciﬁc21 B-cell22 antigen present on lymphoid
cells. CD20 lymphoid marker is used routinely in diag-
nosis of lymphomas. The identiﬁcation of this gene is
thus reassuring and conﬁrms that our search strategy
is able to detect genes already known to be characteristic
of speciﬁc malignancy such as lymphoma.
Phosphatidyl-inositol-3-kinase (PI3K), assumed not
expressed by the second condition, is a key molecule in
intracellular signaling. It transmits signals from the cel-
lular membrane to the nucleus, and its activation leads
to cytokine9 production and cell division. PI3K is also
critical for killing (cytotoxicity) of tumor cells by T
cells17 and natural killer (NK) cells7 [59]. Therefore the
absence of PI3K activation may compromise immune
surveillance and result in environment permissive for
malignant growth. While PI3K is a necessary for sur-
vival of some leukemic cells [55,1], it is conceivable that
in other malignancies, presumably driven by diﬀerent
proliferation signals, the absence of PI3K (with or with-
out dysregulation of T cell and NK surveillance) could
result in clonal proliferation and lymphoma [48,59].
For the leukemia class, we have the following rule:
Leukemia class:
(KIAA0128_gene EXPRESSED) AND (prostaglan-
din_d2_synthase_gene NOT EXPRESSED)
KIAA0128 gene (Septin 6), addressed by the ﬁrst con-
dition, is a member of a family of ﬁlament-forming23 pro-
teins, septins, forming heteropolymer complexes involved
in cytoskeletal organization and cell division. Septin 6 has
been identiﬁed as a fusion partner of the MLL gene in in-
fants with acute leukemias [8,44,47,17]. The MLL gene is
frequently rearranged and fused to partner genes in ALL
and AML. Out of more than 40 gene fusion partners of
MLL gene identiﬁed to-date, three are septins, and the
AML type with the Septin 6 (KIAA0128 gene)—MLL fu-
sion likely represents a subset on infant AML with com-
mon leukemogenesis pathway [29].20 A molecule on the surface of a cell membrane that facilitates the
inﬂow and outﬂow of calcium.
21 Speciﬁc for a particular development path from a stem cell to a
diﬀerentiated (specialized) cell.
22 Bone marrow (B) derived white blood cell.
23 Forming a cellular ‘‘skeleton.’’The second condition is concerned with the absence
prostaglandin D synthase (PGDS) expression. PGDS
is an enzyme active in the production of prostaglandins
(pro-inﬂammatory an anti-inﬂammatory molecules).
Elevated expression of PGDS has been found in brain
tumors, ovarian and breast cancer [50,26], while hema-
topoietic PGDS has not been, to our knowledge, associ-
ated with leukemias.
Viewing the rule as a whole, the absence of PGDS
expression may be a part of the ‘‘molecular signature’’
reﬂecting either the general tissue type (leukocytes) or
the speciﬁc, KIAA0128 (Septin 6) dependent, leukemic
process. Future studies should determine whether the
identiﬁcation of Septin 6 is due to frequent Septin 6—
MLL rearrangements in our series or whether the Septin
6 expression is associated with other types of leukemia
as well. Collectively, these observations could lead to a
more general role for Septin 6 in leukemias with and
without MLL rearrangements.
Lastly, we address the rule found for the CNS class.
CNS class:
(fetus_brain_mRNA_for_membrane_glycoprotein_M6
EXPRESSED) AND (CRMP1_collapsin_response_me-
diator_protein_1 EXPRESSED)
Concerning the ﬁrst condition, the membrane glyco-
protein M6 functions as a neuron-speciﬁc24 calcium
channel. Upon nerve growth factor stimulation the M6
protein appears to promote neuronal diﬀerentiation
[41], and the antibodies against M6 aﬀect the survival
of cerebellar25 neurons [56].
As for the second condition, members of the collap-
sin/semaphorin family,26 including collapsin response
mediator protein 1, CRMP1, play an important role in
proliferation,27 and pathﬁnding of growing axons to
reach their targets in nervous system [12,13]. Both M6
and CRMP1 appear to have multifunctional roles in
shaping neuronal networks, and their function as sur-
vival (M6) and proliferation (CRMP1) signals may be
relevant to growth promotion and malignancy.5. Conclusions
This study aimed to test the feasibility of inducing
simple, rule-based models for gene expression data.
We argue that a major advantage of such models is their
direct interpretability by domain experts. The prediction
results obtained on independent test sets as well expert24 That is, it only operates in nerve cells.
25 A speciﬁc area of the brain.
26 A family of proteins regulating the growth of neurons.
27 Growth.
282 D. Gamberger et al. / Journal of Biomedical Informatics 37 (2004) 269–284analysis of induced rules demonstrate that the chosen
approach, based on the presented subgroup discovery
methodology, can be a useful tool for the detection of
relevant relationships between sample classes (diseases)
and measured gene expression values. In contrast to
other machine learning applications for gene expression
data analysis, we have started from presence call (cate-
gorical) values. Features based on presence call values
are very easy for human interpretation and this signiﬁ-
cantly contributes to rules being accepted as comprehen-
sible disease models.
The interpretation of the subgroup discovery results
yields several biological observations: out of the ﬁve
best-scoring rules (for ﬁve respective problems) selected
for expert evaluation, two (lymphoma and leukemia clas-
ses) are judged as reassuring and three (AML, ALL, and
CNS classes) have a plausible, albeit partially speculative
explanation. Namely, the best-scoring rule for the lym-
phoma class in the multi-class cancer recognition prob-
lem (containing 16,063 attributes) contains a feature
corresponding to a gene routinely used as a marker in
diagnosis of lymphomas (CD20), while the other part
of the conjunction (the PI3K gene) seems to be a plausi-
ble biological co-factor. The best-scoring rule for the leu-
kemia class contains a gene whose relation to the disease
is directly explicable (Septin 6). In the problem of distin-
guishing AML from ALL, the best-scoring rule related
to the AML class connects in a logical conjunction two
genes, GST and leptin (out of 7192 original genes),
whose co-activity was previously under biological inves-
tigation in a model of impaired detoxiﬁcation, and sup-
ports a possibility that they may form a combined
factor relevant to the etiology of AML.
In spite of the number of ﬁndings in agreement with
the bio-medical state-of-the-art, discovery of known
factors in the considered malignancies was not the ulti-
mate goal of this study. The main goal of the method-
ology is the discovery of unknown and never thought-
oﬀ relationships, in a form instantly understandable to
an expert. Such relationships can in turn be tested and
potentially validated by means of current rapidly
advancing bio-medical research and, later, clinical
trials.
Although the subgroup discovery approach empha-
sizes a strong restriction of the hypothesis space with
the intention to prevent data overﬁtting, the results dem-
onstrate that this phenomenon, linked to the overwhelm-
ing number of existing feature combinations in the
attribute-rich domain, can not be completely eliminated,
especially in domains and target classes with a small
number of samples. Therefore, for several target classes
(with fewer than 16 positive examples) we have not been
able to induce a well-generalizing rule submittable to
expert interpretation. It is promising, however, that the
obtained prediction quality of the induced rules grows
very rapidly with the increased size of the training setand we expect to have signiﬁcantly larger gene expression
domains in the near future from which it will be possible
to induce comprehensible, highly reliable, and highly
predictive disease models. This will help in disease pre-
diction and classiﬁcation, and in attempts to better
understand the biology of malignancy, to risk stratify
cancer patients and, in future applications, to implement
treatment strategies targeted at individual patients.Acknowledgments
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